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ABSTRACT 
Aims: We investigated the roles of neuronal-derived nitric oxide (NO) in the modulation of 
spontaneous activity of mouse detrusor smooth muscle. Methods: Detrusor smooth 
muscle strips were isolated from nNOS gene knock-out (nNOS-/-) mice and their wild type 
siblings (nNOS+/+). The properties of smooth muscle cells were assessed using intracellular 
electrophysiology and Ca2+ imaging by laser-scanning confocal microscopy. The effects of 
an nNOS inhibitor, 7-nitro indazole (7-NI) on electrically-evoked contractility were assessed 
using nNOS+/+ mouse detrusor strips. Results: In spontaneously active cells, the frequency 
of spontaneous action potentials (sAPs) and whole cell Ca2+ flashes in nNOS-/- preparations 
was lower than that in the nNOS+/+ preparations. The frequency of sAPs was enhanced by 
a nitric oxide donor, diethylamine NONOate sodium salt (NONOate; 100 µM), both when 
used alone and when the cGMP pathway was blocked by 1H - [1, 2, 4] oxadiazolo [4, 3-a] 
quinoxalin-1-one (ODQ, 10 µM). 7-NI (100 µM) significantly suppressed the 
electrically-evoked contraction of mouse detrusor strips. Conclusions: We suggest that 
neuronal-derived NO facilitates the generation of spontaneous activity via a 
cGMP-independent pathway, and consequently enhances the evoked contraction of 
detrusor. Dysregulation of nNOS containing nerves may underlie bladder pathologies.
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INTRODUCTION 
Detrusor smooth muscle cells (SMCs) of the urinary bladder exhibit spontaneous 
contractile activity during the storage phase. This contractile activity is poorly synchronised 
between cells; thereby, maintaining the shape of the bladder without elevating intravesical 
pressure.1 It appears, however, that there may be alterations in contractile activity in certain 
bladder pathologies; overactive bladder, for example, is characterised by large amplitude, 
slow duration spontane us contractions2 that may arise from increased synchronization of 
spontaneous activity of SMCs.3 
 Neural activation of the bladder has been shown to be mediated by several 
neurotransmitters, but principally by acetylcholine and ATP with species variations in the 
proportions of cholinergic and purinergic control.4-5 Another important neurotransmitter, 
nitric oxide (NO), may be released from motor fibres6, intramural ganglia7, urothelium8, and 
from SMCs of the bladder.9 The application of NO donors reveals immunoreactivity for cyclic 
guanosine monophosphate (cGMP), a second messenger involved in NO signalling, in 
nerves, urothelium and interstitial cells of the bladder, but cGMP immunoreactivity was 
absent in detrusor smooth muscle10-11 suggesting any NO effect is likely to be 
cGMP-independent. The role NO signalling plays in the functioning of the bladder is far 
from clear, with conflicting studies demonstrating relaxation12 and enhancement of evoked 
contraction11,13. Genetic disruption of neuronal-derived NO has been shown to evoke a 
dilated bladder and increased outflow resistance in male mice.14 Another study reported 
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that there is no discernable cystometric effect in young female nNOS-/- mice.15 
 In order to better understand the role of nNOS-derived NO on the spontaneous activity 
of detrusor SMCs, we have studied spontaneous electrical activity and Ca2+ dynamics in 
strips of detrusor dissected from the bladders of nNOS gene-disrupted mice and used 
drugs which enhance or block NO.  
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MATERIALS AND METHODS 
General 
nNOS gene knock-out (nNOS-/-) mice and their wild type siblings (nNOS+/+) were obtained 
from a colony at the John Radcliffe Hospital (Oxford, UK) by backcrossing the nNOS-/- 
(Jackson Laboratory, USA) on a C57BL/6 background. In order to confirm that the nNOS 
gene had been knocked out, mice were bred, chipped, and coded, and tail DNA samples 
were harvested for genotyping with polymerase chain reaction.16 
 Mice of either sex, weighing 20–39 g, were killed by head concussion followed by 
cervical dislocation. Efforts were made to minimise the number of animals used and their 
suffering; all experiments were carried out in accordance with the UK Animals (Scientific 
Procedures) Act 1986 and European Communities Council Directive 86/09/EEC and were 
approved by the Institutional Animal Care and Use Committee of the University of Oxford 
and National Defense Medical Center, Taipei, Taiwan pursuant to the Helsinki Declaration 
and internationally-accepted principles for the care and use of experimental animals. The 
urinary bladder was surgically removed and its ventral wall was opened longitudinally from 
the bladder neck to the top of the dome. The urothelium was either left intact (for 
microelectrode studies) or removed (for tension recording and Ca2+ imaging studies) by 
careful dissection (taking care not to stretch or damage the underlying detrusor muscle). 
Whole layer tissue strips, 6–8 mm long and 1–2 mm wide, which contained a few bundles of 
smooth muscle, were prepared as previously described.17  
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Microelectrode recordings 
Following bridge-balancing to compensate for the tip resistance (200–300 MΩ) of the 
microelectrode and neutralization of the tip capacitance, individual bladder smooth muscle 
cells in muscle bundles were impaled with microelectrodes from the serosal side. 
Membrane potential changes were recorded using a high input impedance amplifier 
(Axoclamp-2B; Axon Instruments, USA), and analysed as previously described.22  
Ca2+ imaging  
Detrusor muscle strips were exposed to 10 µM Oregon Green 488 BAPTA-1 AM (Invitrogen, 
UK) in 1% DMSO/0.2% pluronic F-127 (Sigma, UK) in PSS for 70 min at 33 °C. Each strip 
was then rinsed in PSS for 10 min before transfer to a chamber mounted on the stage of a 
confocal microscope and continuously superfused with standard PSS (bath temperature 35 
°C). Series of images were acquired and analysed as previously described.17 
Tension Recording  
Detrusor strips (approx. 5x1x1 mm; 2–4 mg) were tied at either end with suture (5/0; 
Pearsalls, UK) and mounted vertically in a 0.2 ml capacity organ bath between two 
recessed platinum electrodes through which electrical field stimulation (EFS) was delivered. 
The strips were stretched with an initial force of 1 g, and allowed to equilibrate for at least 
1h prior to starting the experiments. The strips were constantly superfused with PSS (37 °C) 
at a rate of 1 ml.min-1.  
EFS was delivered from a stimulator (Grass S88; Grass Technologies, USA) at 
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parameters of 0.05 ms pulse width, 3 s train duration, 50 V intensity, at varying frequency. 
Isometric tension generated by the strips was measured using isometric force displacement 
transducers (Dynamometer UFI; Pioden Controls Ltd, or AD Instruments MLT050/D), 
amplified and analyzed using PowerLab 4/30 (ADInstruments) and Chart software (v.7). 
Immunohistochemical study 
OCT (0.1 ml) (R.A. Lamb, UK) was injected into the lumen of a whole bladder through the 
urethra. Bladders were mounted in OCT and snap-frozen in isopentane-chilled liquid 
nitrogen. Cryosections (10 µm) were cut and thaw-mounted onto glass slides pretreated 
with Vectabond reagent (Vector Laboratories, UK) and air-dried for 30-60 mins. Sections 
were fixed with acetone for 10 mins and then incubated overnight in a moisture chamber 
with a primary rabbit polyclonal antibody (NOS1[R20]; Santa Cruz, USA), diluted 1:50 with 
phosphate buffered saline (PBS; Oxoid Ltd, UK) and 0.5 % bovine serum albumin (Sigma, 
UK). The next day, slides were washed three times with PBS and then incubated for 30 
mins with secondary antibody (peroxidase conjugated swine anti-rabbit antibody; DAKO, 
UK) at a dilution of 1:50. After being washed, slides were incubated for another 30 mins 
with a tertiary antibody (peroxidase conjugated rabbit anti-swine antibody; DAKO, UK) at a 
dilution of 1:50. Slides were then washed again and incubated in substrate solution made 
with SigmafastTM-diaminodenzidine tablets (Sigma, UK) for 5 mins and then washed. Slides 
were then counterstained with filtered Harris's Hematoxylin (VWR International, UK) for 15 
s, dehydrated with 100% alcohol, and treated with Histoclear (R.A. Lamb, UK). After 
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mounting, slides were dried overnight. Micrographs were obtained by use of a digital 
camera (Coolpix 950; Nikon, Japan) attached to a microscope (DMRB; Leica, UK). 
Drugs and solutions 
To produce stock solutions, diethylamine NONOate sodium salt (NONOate) and 
7-nitroindazole (7-NI; Sigma, UK) were dissolved in distilled water; 
1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; Tocris, UK) was dissolved in dimethyl 
sulfoxide. Stock solutions were stored at -20 °C. Drugs were delivered by substituting PSS 
with drug-containing solutions of the desired concentration for PSS. NONOate was stored 
in dark-coloured vessels in order to minimize light-induced degradation. 
 The PSS used had the following composition (mM): NaCl, 120; KCl, 5.9; MgCl2, 1.2; 
CaCl2 2.5; NaHCO3, 15.5; NaH2PO4, 1.2 and Glucose, 11.5.17 
Analysis of data 
The normality and homogeneity of variance was tested prior to statistical analysis (Excel, 
Microsoft and Graph Pad Prism 5) using Kolmogorov-Smirnov and Levene’s tests, 
respectively (SPSS v16; SPSS Inc., USA). Where data sets did not vary significantly from 
chance (i.e. P > 0.05) for both tests, they are presented as mean ± S.E.M. and the 
Student’s t test was used for comparison unless otherwise stated. In cases where data are 
non-parametric, the presentation method and statistical test are stated. The null hypothesis 
was rejected if P < 0.05. The paired t test or Wilcoxon signed rank test was used to 
compare pre- and post-treatment values of frequency and amplitude of sAPs generated 
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from individual detrusor SMCs. The term na refers to the number of animals; nsmc, number 
of smooth muscle cells; nap, number of spontaneous action potentials. Square brackets are 
used to denote range. 
Page 8 of 30
John Wiley & Sons
Neurourology & Urodynamics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
RESULTS 
Immunohistochemical identification of nNOS 
In order to validate the nNOS-/- strain, nNOS immunohistochemistry was performed. There 
was marked nNOS antibody staining of neurons in the suburothelial and detrusor layers of 
bladder wall and of nerve fibres traversing the detrusor layer in nNOS+/+ mice (na=3) (Fig. 
1a). Large ganglia were most commonly found in the serosal layer (Fig. 1c). These 
structures were not stained in the bladder tissue from nNOS-/- mice (Fig. 1b,d). 
 
General electrical properties 
The resting membrane potentials (RMPs) of the urothelium intact detrusor SMCs, 
determined at the most negative potential between each action potential, was -41 mV in 
both nNOS-/- [range: -35 to -50 mV] and nNOS+/+ [-34 to -59 mV] preparations (na=11, 
nsmc=25 and na=18, nsmc=29, respectively; P=0.9). The membrane potentials were 
interrupted by spontaneous action potentials (sAPs) and frequent spontaneous 
depolarizations (Fig.2a). Many of the properties of sAPs17 were no different between 
nNOS-/- and nNOS+/+ preparations (Table 1). There was, however, a slower rate of decay in 
sAPs of nNOS-/- detrusor SMCs. 
  
The frequency of spontaneous action potentials was lower in nNOS-/- detrusor SMCs 
The frequency of sAPs recorded from the urothelium intact nNOS-/- detrusor SMCs (2.3 ± 
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0.38 min-1, na=13, nsmc=25) was significantly lower in comparison to those recorded from 
the intact nNOS+/+ detrusor SMCs (4.3 ± 0.73 min-1; na=19, nsmc=29; P=0.025, Fig. 2b). 
 
Spontaneous Ca2+ dynamics of nNOS+/+ and nNOS-/- detrusor SMCs 
The frequency of whole cell Ca2+ flashes in nNOS-/- preparations (median frequency: 0 min-1 
range: [0, 19], na=7, nsmc=105) was lower than that in the nNOS+/+ preparations (1.1 min-1 [0, 
58], na=7, nsmc=152) (P < 0.0001, Mann-Whitney U test; Fig. 2c). 
 
Current-voltage relationship of mouse detrusor smooth muscle 
Input resistance was lower in nNOS-/- detrusor SMCs than in nNOS+/+ preparations (470 ± 
16 MΩ vs. 580 ± 13 MΩ; P < 0.0001; na=4, nsmc=10 for nNOS-/-; na=5, nsmc=12 for nNOS+/+) 
(Fig. 3). 
Spontaneous depolarizations recorded from detrusor SMCs 
The frequency of spontaneous depolarizations (SDs) was no different in nNOS-/- (8.7 ± 1.6 
min-1, na=7, nsmc=9) or nNOS+/+ preparations (9.2 ± 1.2 min-1, na=10, nsmc=10) (Figure 4a). 
The shape of SDs did not differ (Table 1), but average SD amplitude was larger in nNOS-/- 
detrusor SMCs (Figure 4b, c). 
 
Effect of a NO donor on nNOS+/+ and nNOS-/- detrusor SMCs 
A nitric oxide donor NONOate was added to nNOS-/- preparations to determine whether the 
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lower sAP frequency of detrusor SMCs in nNOS-/- could be restored to a frequency similar 
to nNOS+/+. NONOate (100 µM) significantly increased the frequency of sAPs in nNOS-/- 
preparations (from 1.9 ± 0.7 min-1 to 9.4 ± 3.3 min-1, na=8, nsmc=10, P=0.048, i.e. to a 
greater frequency than in nNOS+/+, which was 4.3 ± 0.73 min-1). NONOate also reduced the 
amplitude of sAPs (from 54 ± 2.1 mV to 50 ± 2.3 mV, P=0.017) and depolarised the resting 
potential (from -44 ± 1.6 mV to -38 ± 2.6 mV, P=0.015). 
 
Effect of NO-sensitive guanylyl cyclase inhibition on nNOS+/+ detrusor SMCs 
Soluble guanylyl cyclase is normally activated by NO to stimulate cGMP synthesis. A 
selective inhibitor of nitric oxide-sensitive guanylyl cyclase, ODQ, was added to nNOS+/+ 
preparations to block the synthesis of cGMP. ODQ (10 µM) did not significantly affect the 
frequency (control: 1.6 ± 0.7 min-1 vs. ODQ: 3.3 ± 0.7 min-1, P=0.09) or amplitude (control: 
56 ± 0.5 mV vs. ODQ: 55 ± 0.3 mV, P=0.29) of sAPs in nNOS+/+ preparations (na=5, 
nsmc=10). To determine whether NO affects spontaneous electrical activity in the absence of 
cGMP signalling, NONOate (100 µM), added following incubation of the tissue (20 mins) 
with ODQ (10 µM), increased sAP frequency from 3.3 ± 0.7 min-1 to 8.6 ± 1.9 min-1 (na=4, 
nsmc=5, P=0.012; Fig. 5). Adding ODQ subsequently did not affect the frequency of sAPs 
(NONOate + ODQ: 8.6 ± 1.9 min-1 vs. NONOate: 6.3 ± 2.4 min-1, na=4, nsmc=5 for NONOate 
+ ODQ, na=6, nsmc=6 for NONOate, P=0.48). 
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Effect of nNOS inhibition on EFS-evoked contraction of detrusor
 
In order to determine the effect of nNOS inhibition on EFS-evoked contractions, 
force-frequency relationships of nNOS+/+ detrusor were compared in the presence and 
absence of the nNOS inhibitor 7-NI. 7-NI (100 µM) significantly reduced the amplitude of 
EFS-evoked contractions at all frequencies (e.g. control amplitude at 20 Hz: 1.39 ± 
0.14 g.mg-1 vs. 7-NI: 1.10 ± 0.12 g.mg-1; P < 0.0001, na =15) (Fig. 6a). 
In order to determine whether there was an interaction between nNOS-derived NO and 
purinergic neurotransmission, force-frequency relationships were compared following 
purinoceptor desensitization by α,β-methylene ATP (α,β-mATP). α,β-mATP (3 µM) 
significantly reduced the force-frequency relationship (e.g. control amplitude at 20 Hz: 1.01 
± 0.16 g.mg-1 vs. α,β-mATP: 0.49 ± 0.07 g.mg-1; repeated measures ANOVA, P < 0.001, na 
=12). When detrusor strips were treated with 7-NI (100 µM) in the presence of α,β-mATP (3 
µM), there was no additional reduction in the force-frequency relationship (e.g. α,β-mATP at 
20 Hz: 0.49 ± 0.07 g.mg-1 vs. 0.47 ± 0.07 g.mg-1; P=NS) (Fig. 6b). On a strip-by-strip basis, 
this was a mean reduction of 7 ± 6% by  α,β-mATP (3 µM) plus 7-NI (100 µM) compared to 
the effect of 7-NI (100 µM). 
In order to determine whether there was an interaction between nNOS-derived NO and 
cholinergic neurotransmission, force frequency relationships were compared following 
muscarinic cholinergic receptor antagonism by atropine (1 µM). Atropine (1 µM) 
significantly reduced the force-frequency relationship (e.g. control amplitude at 20 Hz: 0.78 
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± 0.09 g.mg-1 vs. atropine: 0.25 ± 0.04 g.mg-1; P < 0.001, na =18). When detrusor strips 
were treated with 7-NI (100 µM) in the presence of atropine (1 µM), there was an additional 
reduction in force generated, of 38 ± 8% (to 0.16 ± 0.04 g.mg-1), relative to treatment by 
atropine alone (0.25 ± 0.04 g.mg-1) (0.1>P>0.05, paired t test) (Fig. 6c).
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DISCUSSION 
Spontaneous activity of the detrusor during the filling phase of the micturition cycle is of 
clinical relevance because bladder overactivity, a common and debilitating condition, is 
characterised by larger amplitude, fused spontaneous contractions of the detrusor.2 By 
comparing nNOS knock-out and sibling control mice we demonstrate that neuronal-derived 
NO plays an important role in generating and modulating the spontaneous activity of the 
detrusor. 
 
Confirmation of disruption of nNOS gene by lack of immunoreactivity 
Genetically-modified mice were used in the present study. The nNOS-/- strain used was 
originally developed by Huang et al. 18, and has previously been used to investigate the role 
of NO in bladder function.14-15 Despite only the nNOSα splice variant being knocked-out in 
this nNOS-/- strain (i.e. meaning that the β-, γ- and µ−variants may still be present) neuronal 
nNOS containing neurons were absent (Figure 1), consistent with previous studies using 
the same strain of nNOS gene-disrupted mice14-15 and validating the use of this strain as a 
true nNOS-/-. 
 
nNOS derived NO enhances the spontaneous activity of the detrusor 
Detrusor SMCs generate sAPs caused by the opening of L-type Ca2+ channels and 
regulated by voltage-dependent mechanisms19. We used intracellular electrophysiology 
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and confocal imaging to detect the spontaneous activity of detrusor SMCs. The frequency 
of these two measures of cellular activity was significantly lower in the nNOS-/- detrusor 
SMCs. After applying an NO donor (NONOate), the frequency of sAPs was augmented. 
This suggests that nNOS derived NO may play an excitatory role in the generation of sAPs 
and probably increase detrusor excitability; a finding that is consistent with previous 
research. 20  
It has been demonstrated that NO, acting through S-nitrosylation pathways, acts as an 
excitatory agent in the regulation of electrical activity of excitable cells.21 Recently, Yoshida 
and colleagues22 presented a mechanism mediated by cysteine S-nitrosylation showing 
that NO may activate Transient Receptor Potential (TRP) channels and elicit entry of Ca2+ 
into human embryonic kidney cells, thereby causing excitation. Consistent with these 
studies, we demonstrated that NONOate enhanced the frequency of sAPs when the cGMP 
pathway was blocked by ODQ, suggesting NO may excite detrusor smooth muscle cells via 
a cGMP-independent pathway. 
There were no significant differences in sAP waveform from nNOS-/- and nNOS+/+ 
detrusor apart from a small but significant difference in rate of decay. This change is similar 
to the change in the shape of sAPs after applying a Ca2+-activated K+ channel blocker, 
charybdotoxin in guinea pig bladder SMCs19, suggesting that the lack of NO in nNOS-/- 
mice may result in reduced function of the Ca2+-activated K+ channels23 and/or 
Ca2+-mediated inactivation of the Ca2+ channels19, and consequently reduced the 
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frequency of sAPs. 
Input resistance is negatively correlated with the degree of electrical connectivity of 
SMCs local to the site of impalement.24 SMCs of nNOS-/- preparations exhibited lower input 
resistance compared to nNOS+/+ preparations, indicating a greater degree of electrical 
coupling of SMCs in nNOS-/- detrusor muscle. The functional implications are not currently 
clear; perhaps increased intercellular coupling helps generate additional voiding pressure.  
In a previous study we demonstrated that SDs, or spontaneous excitatory junctional 
potentials, occur when the magnitude of the current influx through P2X1 is insufficient to 
trigger a sAP.25 It follows that the observation that nNOS-/- detrusor SMCs exhibit higher 
amplitude SDs and less frequent sAPs in nNOS-/- compared to nNOS+/+ suggests that the 
size of nerve-released ATP packets in nNOS-/- is reduced. NO and ATP have been 
recognized as co-transmitters in the non-adrenergic non-cholinergic nerves.26 Therefore, 
absence of neuronal-derived NO may possibly reduce the amount of ATP in synaptic 
vesicles, reducing sAP frequency and consequently suppress detrusor contraction. This 
theory is supported by our tension recording experiments, in which a nNOS inhibitor, 7-NI, 
suppressed EFS-evoked contraction. No additional reduction of detrusor contractility was 
observed when 7-NI was subsequently applied in the presence of blockers of purinergic or 
cholinergic neurotransmission, implying that neuronal-derived NO may modulate the 
evoked contractility of detrusor pre- rather than post-junctionally. 
A previous study has found that there are only interstitial cells and nerve fibres in the 
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mouse bladder wall respond to NO.27 Fujiwara and colleagues demonstrated that EFS and 
the NO donor SIN-1 failed to induce relaxation of pre-contracted mouse detrusor 
preparations. In addition, SIN-1 and sodium nitroprusside were found to increase cGMP 
levels in the bladder tissue, but this increase was not correlated to smooth muscle 
relaxation.11 Therefore it is unlikely that NO causes relaxation of mouse detrusor smooth 
muscle.11,28 Our data are in line with these studies and further demonstrated that 
nerve-derived NO plays an excitatory role in modulating mouse detrusor activity. 
 
CONCLUSION 
The present study suggests that neuronal-derived NO facilitates the generation of 
spontaneous activity via a cGMP-independent pathway, and contributes to the evoked 
contractility of detrusor. 
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Table 1. Descriptive statistics of the properties of sAPs and SDs recorded from nNOS+/+ 
and nNOS-/- detrusor SMCs. 
 
 nNOS+/+ nNOS-/- Significance (P) 
Shape17 
   Spike-type (%) 
   Pacemaker-type (%) 
sAPs 
 
26 
74 
 
20 
80 
 
0.4 
   Amplitude (mV) 54 ± 1.0 53 ± 1.0 0.5 
   Half-width (ms) 7 ± 1.0 8 ± 0.3 0.17 
   Rise time (ms) 33 ± 3.2 38 ± 3.4 0.17 
   Rising slope (mV.ms-1) 8.5 ± 0.5 7.3 ± 0.4 0.08 
   Rate of decay (mV.ms-1) 
   After-hyperpolarization amplitude (mV) 
13 ± 0.5 
9.1 ± 0.7 
11 ± 0.6 
8.8 ± 0.5 
0.017 
0.69 
   na 
   nsmc 
SDs 
   Amplitude (mV) 
   Half-width (ms) 
   Rise-time (ms) 
   Time constant of decay (ms) 
   nsmc 
19 
29 
 
6.2 ± 0.5 
51 ± 5.7 
32 ± 2.5 
46 ± 5.2 
10 
13 
25 
 
7.7 ± 0.3 
64 ± 4.9 
29 ± 19 
55 ± 4.5 
9 
 
 
 
0.016 
0.13 
0.43 
0.22 
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FIGURE LEGENDS 
Figure 1. nNOS immunoreactivity was absent in nNOS-/- mouse bladder tissue. (a) 
nNOS positive ganglia (arrow) are seen in the serosal and detrusor layers in nNOS+/+, but 
(b) not in nNOS-/- bladder tissue. (c) At higher magnification nNOS positive staining of a 
ganglion (asterisk) and of nerve fibres (arrow head) was seen near the serosa of nNOS+/+ 
bladder, but (d) not in nNOS-/-, but not in bladder tissue. 
Figure 2. Spontaneous action potentials and whole cell Ca2+ flashes were less frequent in nNOS-/- that 
nNOS+/+ siblings. (a) Intracellular recordings from a nNOS+/+ and a nNOS-/- SMC. Resting membrane 
potentials were -40 mV for nNOS+/+ and -43 mV for nNOS-/-. (b) The frequency of sAPs in lower in SMCs from 
nNOS-/- than nNOS+/+ mice. The data shown are the mean and SEM.  denotes P < 0.05 (na=18, nsmc=29 for 
intact nNOS+/+; na=11, nsmc=25 for intact nNOS-/-). (c) The frequency of spontaneous whole cell flashes was 
greater in SMCs from nNOS+/+ mice (na=7, nsmc=152) than from nNOS-/- mice (na=5, nsmc=105). There was, 
however, no significant difference in the whole cell flash amplitudes between the two groups (∆F/F of 0.29, 
nsmc=47, in nNOS-/- preparations and 0.27, nsmc=110, in nNOS+/+ preparations). Frequent Ca2+ waves and 
focal Ca2+ transients could also be seen within the individual smooth muscle cells, but their frequencies were 
not quantified as part of the present study. Data shown are frequencies and amplitudes per cell (symbols) and 
median per group (horizontal line). Statistical comparisons are Mann Whitney U test. 
 
Figure 3. nNOS-/- detrusor SMCs had a lower input resistance compared to nNOS+/+ detrusor SMCs. 
The membrane properties of nNOS+/+ and nNOS-/- mouse detrusor SMCs were examined by a series of brief 
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intracellular current injections (-0.1 to 0.1 nA for 100 ms). The current-voltage relationship for SMCs in 
nNOS+/+ and nNOS-/- was linear before the threshold of generating an action potential was reached (value of 
membrane potential: 0 ± 2.2 mV for nNOS+/+ and -10 ± 2.2 mV for nNOS-/-). The input resistances of the 
detrusor SMCs calculated from a slope of the linear current-voltage relationship is significantly lower in 
nNOS-/- preparations. The time constants of decay of the resultant electrotonic potential in SMCs were not 
significantly different (7.9 ± 0.9 ms vs. 7.6 ± 0.7 ms, P=0.8). The fitted line above this threshold is a third-order 
polynomial. (na=5, nsmc=12 for nNOS+/+; na=4, nsmc=10 for nNOS-/-). 
Figure 4. Larger amplitude spontaneous depolarizations (SDs) occurred more frequently in nNOS-/- 
than nNOS+/+. (a) The frequency of SDs occurred in detrusor SMCs was no different in nNOS-/- mice (na=7, 
nsmc=9) compared to that in nNOS+/+ mice (na=10, nsmc=10) (P=NS). (b) However, the amplitude distribution 
was shifted to the right in nNOS-/- mouse detrusor SMCs, as demonstrated (c) by the corresponding 
significant difference in median amplitude between nNOS+/+ and nNOS-/- mouse detrusor SMCs. 
Figure 5. NONOate enhanced the spontaneous activity of detrusor in the presence of a selective 
inhibitor of nitric oxide-sensitive guanylyl cyclase, ODQ (10 µM), in the nNOS+/+ mouse. (a) In the 
presence of ODQ, NONOate (100 µM) significantly increased the frequency of sAPs (b) ODQ (10 µM) alone 
did not increase sAP frequency in nNOS+/+ detrusor SMCs (na=4). Statistical comparisons are one-way 
ANOVA followed by Tukey’s multiple comparison test. ** denotes P < 0.01 *** denotes P < 0.001. 
Figure 6. The nNOS inhibitor 7-NI reduced EFS-stimulated detrusor contracture but there was no 
additional reduction following purinergic desensitisation or cholinergic blockade. (a) 7-NI (100 µM) 
suppressed the EFS evoked contraction of nNOS+/+ detrusor smooth muscle strips (na=15). (b) P2X1 receptor 
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desensitisation, by α,β-methylene, ATP (3 µM) reduced EFS-evoked contracture but there was no additive 
reduction of contraction by 7-NI (100 µM) in combination with α,β-methylene ATP (3 µM) (na=12). (c) The 
force-frequency relationship in the presence of 7-NI (100 µM) and atropine (1 µM) and (cii) contracture at 20 
Hz exhibited a borderline significant reduced contracture compared to that in the presence of atropine alone 
(na=18). See text for details. 
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Figure 1. nNOS immunoreactivity is absent in nNOS-/- mouse bladder tissue. (a,) nNOS positive ganglia 
(arrow) are seen in the serosal and detrusor layers in nNOS+/+, but  not in nNOS-/- bladder tissue, (b). (c) 
At higher magnification nNOS positive staining of a ganglion (asterisk) and of nerve fibres (arrow head) was 
seen near the serosa of nNOS+/+ bladder, but not in nNOS-/- , but not in bladder tissue (d).  
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Figure 2. Spontaneous action potentials and whole cell Ca2+ flashes are less frequent in nNOS-/- that 
nNOS+/+ siblings.  (a) Intracellular recordings from a nNOS+/+ and a nNOS-/- SMC. Resting membrane 
potentials were -40 mV for nNOS+/+ and -43 mV for nNOS-/-. (b) The frequency of sAPs SMCs from nNOS-
/- mice was significantly lower compared to that from nNOS+/+ mice. The data shown are the mean and 
SEM. ∗denotes P < 0.05 (na = 18, nsmc = 29 for intact nNOS+/+; na = 11, nsmc = 25 for intact nNOS-/-). 
(c)The frequency of spontaneous whole cell flashes was greater in SMCs from nNOS+/+ mice (na = 7, nsmc 
= 152) than from nNOS-/- mice. ∗∗∗denotes P < 0.001 (na = 5, nsmc = 105). There was, however, no 
difference in the whole cell flash amplitudes between nNOS+/+ (nsmc = 110) and nNOS-/- mice (nsmc = 
47). Data shown are frequencies and amplitudes per cell (symbols) and median per group (horizontal line). 
Statistical comparisons are Mann Whitney U test.  
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Figure 3. nNOS-/- detrusor SMCs have a lower input resistance compared to nNOS+/+ detrusor SMCs. The 
current-voltage relationship for SMCs in nNOS+/+ and nNOS-/- was linear before the threshold of 
generating an action potential was reached (value of membrane potential: 0 ± 2.2 mV for nNOS+/+ and -10 
± 2.2 mV for nNOS-/-). The input resistances of the detrusor SMCs calculated from a slope of the linear 
current-voltage relationship is significantly lower in nNOS-/- preparations. The fitted line above this 
threshold is a third-order polynomial. (na = 5, nsmc = 12 for nNOS+/+; na = 4, nsmc = 10 for nNOS-/-).  
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Figure 4. Larger amplitude spontaneous depolarizations (SDs) occurred more frequently in nNOS-/- than 
nNOS+/+. (a) The frequency of SDs occurred in detrusor SMCs was no different in nNOS-/- mice (na = 7, 
nsmc = 9) compared to that in nNOS+/+ mice (na = 10, nsmc = 10) (P = NS). (b) However, the amplitude 
distribution was shifted to the right in nNOS-/- mouse detrusor SMCs, as demonstrated (c) by the 
corresponding significant difference in median amplitude between nNOS+/+ and nNOS-/- mouse detrusor 
SMCs.  
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Page 28 of 30
John Wiley & Sons
Neurourology & Urodynamics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure 5. NONOate enhanced the spontaneous activity of detrusor in the presence of a selective inhibitor of 
nitric oxide-sensitive guanylyl cyclase, ODQ (10 µM), in the nNOS+/+ mouse. (a) In the presence of ODQ, 
NONOate (100 µM) significantly increased the frequency of sAPs (b) ODQ (10 µM) alone did not increase sAP 
frequency in nNOS+/+ detrusor SMCs (na = 4). Statistical comparisons are one-way ANOVA followed by 
Tukey’s multiple comparison test. ∗∗  denotes P < 0.01, ∗∗∗ denotes P < 0.001.  
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Figure 6. The nNOS inhibitor 7-NI reduced EFS-stimulated detrusor contracture but there was no additional 
reduction following purinergic desensitisation or cholinergic blockade. (a) 7-NI (100 µM) suppressed the EFS 
evoked contraction of nNOS+/+ detrusor smooth muscle strips (na=15). (b) P2X1 receptor desensitisation, 
by α,β-methylene, ATP (3 µM) reduced EFS-evoked contracture but there was no additive reduction of 
contraction by 7-NI (100 µM) in combination with α,β-methylene ATP (3 µM) (na=12). (c) The force-
frequency relationship in the presence of 7-NI (100 µM) and atropine (1 µM) and (cii) contracture at 20 Hz 
exhibited a borderline significant reduced contracture compared to that in the presence of atropine alone 
(na=18). See text for details.  
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